NCT02618941View on ClinicalTrials.gov

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions

Parkinson's Disease

Interventions

BIOLOGICAL

AFFITOPE® PD01A

s.c. injection

Trial Locations (1)

1080

Studienzentrum der PROSENEX, AmbulatoriumsbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Vienna

All Listed Sponsors

lead

Affiris AG

INDUSTRY

NCT02618941 - Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA) | Biotech Hunter | Biotech Hunter